Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases. Authors' reply

Aliment Pharmacol Ther. 2024 Feb;59(4):585-586. doi: 10.1111/apt.17877.

Authors

Mary Thomson¹, Adam Scott², Suzanne Trost³, Jack Lake¹, Nicholas Lim¹

Affiliations

¹ Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
² University of Minnesota Medical School, Minneapolis, Minnesota, USA.
³ Division of Diabetes, Endocrinology and Metabolism, University of Minnesota, Minneapolis, Minnesota, USA.

PMID: 38247149
DOI: 10.1111/apt.17877

No abstract available

Publication types

Letter
Comment

MeSH terms

Cholestasis* / diagnosis
Humans
Liver Diseases* / complications
Liver Diseases* / diagnosis
Longitudinal Studies